HeartCore Reports Third Quarter 2026 Financial Results
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
HeartCore (HTCR) reported third-quarter 2026 revenue of $162,000, down from the same period last year as Go IPO activity slowed. Revenue was $1.2 million a year earlier. Net loss was $596,000, versus net income of $351,000, while operating expenses rose to $1.2 million from $899,000.
For the nine months ended September 30, revenue fell to $269,852 from $1,666,519, and net loss widened to $3,792,658 from $1,724,700. Cash and cash equivalents were $976,594, versus $1,530,967 at December 31, 2025.
HeartCore completed the sale of its 51% HeartCore Luvina stake for JPY 29,000,000, approximately $184,000, concluding its exit from software development services. It also signed a non-exclusive sales agency agreement with ONE AI in Japan. At September 30, HeartCore had 16 Go IPO clients, including six preparing for potential IPOs and U.S. exchange listings.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate pointHeartCore Luvina's 51% stake sale for JPY 29,000,000, approximately $184,000, completed the software development services exit. 8.7% of market cap
- Moderate pointTotal liabilities fell to $2,150,695 at September 30, 2026, from $4,988,617 at December 31, 2025.
- Minor point. Forward-looking: it has not happened yet and may not happen.ONE AI's non-exclusive Japan sales agency agreement adds a commission-based revenue stream for HeartCore.
- Minor pointNine-month selling expenses fell to $104,021 from $296,632 a year earlier.
- Minor pointNine-month net other expenses narrowed to $564,558 from $951,368 a year earlier.
- Minor pointNine-month income tax benefit was $766,504, versus a $33,377 expense a year earlier.
Negative
- Moderate pointThird-quarter revenue fell to $162,000 from $1.2 million a year earlier, reflecting fewer clients and successful IPOs.
- Moderate pointThird-quarter net loss was $596,000, versus net income of $351,000 a year earlier.
- Moderate pointNine-month revenue fell to $269,852 from $1,666,519 a year earlier.
- Moderate pointNine-month net loss widened to $3,792,658 from $1,724,700 a year earlier.
- Moderate pointCash fell to $976,594 at September 30, 2026, from $1,530,967 at December 31, 2025.
- Moderate pointMarketable securities fell to $1,380,553 at September 30, 2026, from $3,690,187 at December 31, 2025.
- Moderate pointCommon shares outstanding increased to 1,515,328 at September 30, 2026, from 1,270,991 at December 31, 2025.
- Moderate pointClient IPO timelines have extended; HeartCore attributes the delays to stricter exchange and regulatory requirements.
9 minor points
- Minor pointThird-quarter gross profit fell to $16,000 from $1.1 million a year earlier.
- Minor pointThird-quarter operating expenses rose to $1.2 million from $899,000 a year earlier.
- Minor pointThird-quarter adjusted EBITDA, a non-GAAP earnings measure, was negative $1.1 million, versus positive $0.4 million a year earlier.
- Minor pointNine-month gross loss was $259,710, versus gross profit of $1,334,557 a year earlier.
- Minor pointNine-month general and administrative expenses rose to $2,986,544 from $2,488,822 a year earlier.
- Minor pointNine-month basic and diluted loss per share widened to $2.68 from $1.43 a year earlier.
- Minor pointNine-month discontinued operations lost $644,329, versus income of $710,942 a year earlier.
- Minor pointNine-month adjusted EBITDA was negative $3.2 million, versus negative $0.8 million a year earlier.
- Minor pointTotal shareholders' equity fell to $5,992,518 at September 30, 2026, from $8,072,860 at December 31, 2025.
News Explained
The release reports common shares issued and outstanding rose from
Key Figures
- Q3 revenue
- $162,000 vs. $1.2 million
- Third quarter 2026 vs. same period last year
- Q3 gross profit
- $16,000 vs. $1.1 million
- Third quarter 2026 vs. same period last year
- Q3 net income (loss)
- Net loss of $596,000 vs. net income of $351,000
- Third quarter 2026 vs. same period last year
- Q3 Adjusted EBITDA
- $(1.1) million vs. $0.4 million
- Third quarter 2026 vs. same period last year
- Nine-month gross profit (loss)
- Gross loss of $260,000 vs. gross profit of $1.3 million
- Nine months ended September 30, 2026 vs. same period last year
- Nine-month net loss
- $3.8 million vs. $1.7 million
- Nine months ended September 30, 2026 vs. same period last year
- Nine-month Adjusted EBITDA
- $(3.2) million vs. $(0.8) million
- Nine months ended September 30, 2026 vs. same period last year
- Cash and cash equivalents
- $1.0 million vs. $1.5 million
- As of September 30, 2026 vs. December 31, 2025
Previous Earnings Reports
-
Revenue rose on Luvina services, but gross and net losses widened before its divestiture.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
adjusted ebitda financial
non-gaap financial measure financial
gaap financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK and TOKYO, Nov. 16, 2026 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, reported financial results for the third quarter and nine months ended September 30, 2026.
Recent Operational Highlights
- Entered into a non-exclusive business development and sales agency agreement in Japan with ONE AI, Co., Ltd. (“ONE AI”)
- As of September 30, 2026, HeartCore was engaged with 16 Go IPO clients, including 6 clients currently in various stages of preparation for potential initial public offerings and U.S. exchange listings.
- Announced and completed the transfer of the Company’s
51% equity interest in HeartCore Luvina Vietnam Company Limited (“HeartCore Luvina”) to Luvina Software Joint Stock Company for JPY 29,000,000 (approximately$184,000 ). Together with the June 2026 divestiture of Sigmaways, Inc., the transaction concludes the Company’s exit from software development services and concentrates its operations on Go IPO consulting, capital markets advisory, and financial services.
Management Commentary
HeartCore CEO Sumitaka Kanno commented: “With the transfer of our interest in HeartCore Luvina completed during the third quarter, we have concluded the portfolio optimization we began earlier this year. HeartCore now operates as a focused Go IPO consulting, capital markets advisory, and financial services company, which we believe allows us to direct management attention and capital toward the areas where we see the greatest long-term opportunity.
“The Nasdaq listing environment remains selective, and a number of our clients have extended their IPO timelines as they work to satisfy stricter exchange and regulatory requirements. We continue to prioritize clients that we believe demonstrate stronger fundamentals, organizational readiness, and a clear path to a U.S. listing, and we are cautiously optimistic that this disciplined approach will support a higher-quality pipeline over time.
“Beyond our core business, just last week, we announced a new business development and sales agency agreement with ONE AI. Under this agreement, we will support ONE AI’s commercial expansion into the Japanese robotics market. Importantly, the agreement introduces an additional commission-based revenue stream, further diversifying our revenue base as we continue to navigate the current U.S. listing environment.
“Looking ahead, we intend to maintain disciplined cost management as we work to convert our pipeline into new engagements and listing milestones. With a simpler structure in place, we expect our results going forward to more clearly reflect the performance of our core business.”
Third Quarter 2026 Financial Results
Revenues were
Gross profit was
Operating expenses were
Net loss was
Adjusted EBITDA was
Nine Months Ended September 30, 2026 Financial Results
Revenues were
Gross loss was
Operating expenses were
Net loss was
Adjusted EBITDA was
As of September 30, 2026, the Company had cash and cash equivalents of
About HeartCore Enterprises, Inc.
HeartCore Enterprises, Inc. is headquartered in Tokyo, Japan, and is a leading consulting services company providing U.S. market listing support and related advisory services primarily to Japanese corporate clients. For more information, please visit https://heartcore-enterprises.com/.
Non-GAAP Financial Measures
This document includes references to Adjusted EBITDA, which is a non-GAAP financial measure. For the purposes of this presentation, Adjusted EBITDA is calculated by adjusting net loss to exclude depreciation and amortization, changes in fair value of investments in marketable securities, changes in fair value of investment in warrants, changes in fair value of derivative liability, interest income, interest expenses, other income, and other expenses.
This measure is presented as supplemental information and is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the U.S. (“GAAP”).
Management believes that Adjusted EBITDA provides useful information to investors by highlighting the Company’s core operational performance, excluding non-cash and non-recurring items. However, non-GAAP financial measures have limitations and should not be considered in isolation or as a substitute for financial results prepared in accordance with GAAP.
For the three months ended September 30,
| Item | 2026 | 2025 |
| Net income (loss) | ||
| (+) Depreciation | ||
| (+) Changes in fair value of investments in marketable securities | ||
| (+) Changes in fair value of investment in warrants | ||
| (+) Changes in fair value of derivative liability | ||
| (+) Interest income | ||
| (+) Interest expenses | ||
| (+) Other income | ||
| (+) Other expenses | ||
| Adjusted EBITDA |
For the nine months ended September 30,
| Item | 2026 | 2025 |
| Net loss | ||
| (+) Depreciation | ||
| (+) Changes in fair value of investments in marketable securities | ||
| (+) Changes in fair value of investment in warrants | ||
| (+) Changes in fair value of derivative liability | ||
| (+) Interest income | ||
| (+) Interest expenses | ||
| (+) Other income | ||
| (+) Other expenses | ||
| Adjusted EBITDA |
Note: Figures in the tables above are rounded to the nearest
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, or the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believed,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.
HeartCore Investor Relations Contact:
Gateway Group, Inc.
John Yi and Steven Shinmachi
HTCR@gateway-grp.com
(949) 574-3860
| HEARTCORE ENTERPRISES, INC. | |||||||
| UNAUDITED CONSOLIDATED BALANCE SHEETS | |||||||
| September 30, | December 31, | ||||||
| 2026 | 2025 | ||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 976,594 | $ | 1,530,967 | |||
| Accounts receivable | 32,853 | - | |||||
| Investments in marketable securities | 1,380,553 | 3,690,187 | |||||
| Prepaid expenses | 82,351 | 127,242 | |||||
| Deferred offering costs | 250,000 | 250,000 | |||||
| Other current assets | 144,079 | 188,525 | |||||
| Current assets of discontinued operations | - | 1,337,673 | |||||
| Proceeds receivable from sale of discontinued operations | 483,082 | 1,291,298 | |||||
| Total current assets | 3,349,512 | 8,415,892 | |||||
| Non-current assets: | |||||||
| Property and equipment, net | 255,872 | 275,465 | |||||
| Operating lease right-of-use assets | 352,524 | 16,986 | |||||
| Long-term investment in warrants | 130,916 | 280,924 | |||||
| Long-term loan receivable | 258,859 | - | |||||
| Deferred tax assets | 23,006 | 23,121 | |||||
| Security deposits | 276,199 | 278,342 | |||||
| Other non-current assets | 286 | - | |||||
| Non-current assets of discontinued operations | - | 33,752 | |||||
| Long-term proceeds receivable from sale of discontinued operations | 3,496,039 | 3,736,995 | |||||
| Total non-current assets | 4,793,701 | 4,645,585 | |||||
| Total assets | $ | 8,143,213 | $ | 13,061,477 | |||
| LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||
| Current liabilities: | |||||||
| Accounts payable and accrued expenses | $ | 454,345 | $ | 275,412 | |||
| Accrued payroll and other employee costs | 41,859 | 41,073 | |||||
| Due to related party | 423 | 285 | |||||
| Insurance premium financing | 33,736 | 13,430 | |||||
| Operating lease liabilities, current | 284,622 | 16,986 | |||||
| Income tax payables | 20,564 | 1,038 | |||||
| Deferred revenue | 438,862 | 676,216 | |||||
| Derivative liability | 62,507 | 121,719 | |||||
| Other current liabilities | 530,070 | 521,607 | |||||
| Current liabilities of discontinued operations | - | 1,833,294 | |||||
| Total current liabilities | 1,866,988 | 3,501,060 | |||||
| Non-current liabilities: | |||||||
| Operating lease liabilities, non-current | 71,912 | - | |||||
| Deferred tax liabilities | 211,795 | 1,039,181 | |||||
| Non-current liabilities of discontinued operations | - | 448,376 | |||||
| Total non-current liabilities | 283,707 | 1,487,557 | |||||
| Total liabilities | 2,150,695 | 4,988,617 | |||||
| Shareholders' equity: | |||||||
| Preferred shares, | 351,712 | 691,858 | |||||
| Common shares, | 151 | 127 | |||||
| Additional paid-in capital | 22,309,504 | 21,902,169 | |||||
| Accumulated deficit | (16,640,902 | ) | (12,965,525 | ) | |||
| Accumulated other comprehensive loss | (27,947 | ) | (58,497 | ) | |||
| Total HeartCore Enterprises, Inc. shareholders' equity | 5,992,518 | 9,570,132 | |||||
| Non-controlling interests | - | (1,497,272 | ) | ||||
| Total shareholders' equity | 5,992,518 | 8,072,860 | |||||
| Total liabilities and shareholders' equity | $ | 8,143,213 | $ | 13,061,477 | |||
| HEARTCORE ENTERPRISES, INC. | |||||||||
| UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) | |||||||||
| For the Nine Months | |||||||||
| Ended September 30, | |||||||||
| 2026 | 2025 | ||||||||
| Revenues | $ | 269,852 | $ | 1,666,519 | |||||
| Cost of revenues | 529,562 | 331,962 | |||||||
| Gross profit (loss) | (259,710 | ) | 1,334,557 | ||||||
| Operating expenses: | |||||||||
| Selling expenses | 104,021 | 296,632 | |||||||
| General and administrative expenses | 2,986,544 | 2,488,822 | |||||||
| Total operating expenses | 3,090,565 | 2,785,454 | |||||||
| Income (loss) from continuing operations | (3,350,275 | ) | (1,450,897 | ) | |||||
| Other income (expenses): | |||||||||
| Changes in fair value of investments in marketable securities | (375,367 | ) | (908,416 | ) | |||||
| Changes in fair value of investment in warrants | (7,493 | ) | (74,109 | ) | |||||
| Changes in fair value of derivative liability | (630 | ) | (9,679 | ) | |||||
| Interest income | 1,100 | 3,966 | |||||||
| Interest expenses | (6,386 | ) | (8,569 | ) | |||||
| Other income | 186,056 | 45,632 | |||||||
| Other expenses | (361,838 | ) | (193 | ) | |||||
| Total other income (expenses) | (564,558 | ) | (951,368 | ) | |||||
| Income (loss) from continuing operations before income tax expense (benefit) | (3,914,833 | ) | (2,402,265 | ) | |||||
| Income tax expense (benefit) | (766,504 | ) | 33,377 | ||||||
| Net income (loss) from continuing operations | (3,148,329 | ) | (2,435,642 | ) | |||||
| Income (loss) from discontinued operations, net of income tax | (644,329 | ) | 710,942 | ||||||
| Net income (loss) | (3,792,658 | ) | (1,724,700 | ) | |||||
| Less: income (loss) from discontinued operations attributable to non-controlling interests | (117,281 | ) | (171,682 | ) | |||||
| Net income (loss) attributable to HeartCore Enterprises, Inc. | (3,675,377 | ) | (1,553,018 | ) | |||||
| Dividends accrued on Series A convertible preferred shares | (62,530 | ) | (56,833 | ) | |||||
| Net income (loss) attributable to HeartCore Enterprises, Inc. common shareholders | $ | (3,737,907 | ) | $ | (1,609,851 | ) | |||
| Other comprehensive income (loss): | |||||||||
| Foreign currency translation adjustment | (72,706 | ) | 9,668 | ||||||
| Cumulative translation adjustment reclassified into earnings due to disposal of discontinued operations | 94,751 | - | |||||||
| Total comprehensive income (loss) | (3,770,613 | ) | (1,715,032 | ) | |||||
| Less: comprehensive income (loss) attributable to non-controlling interests | (125,786 | ) | (175,353 | ) | |||||
| Comprehensive income (loss) attributable to HeartCore Enterprises, Inc. | $ | (3,644,827 | ) | $ | (1,539,679 | ) | |||
| Net income (loss) from continuing operations attributable to HeartCore Enterprises, Inc. per common share* | |||||||||
| Basic | $ | (2.30 | ) | $ | (2.22 | ) | |||
| Diluted | $ | (2.30 | ) | $ | (2.22 | ) | |||
| Income (loss) from discontinued operations per common share* | |||||||||
| Basic | $ | (0.38 | ) | $ | 0.78 | ||||
| Diluted | $ | (0.38 | ) | $ | 0.78 | ||||
| Net income (loss) attributable to HeartCore Enterprises, Inc. per common share* | |||||||||
| Basic | $ | (2.68 | ) | $ | (1.43 | ) | |||
| Diluted | $ | (2.68 | ) | $ | (1.43 | ) | |||
| Weighted average common shares outstanding* | |||||||||
| Basic | 1,395,177 | 1,124,484 | |||||||
| Diluted | 1,395,177 | 1,124,484 | |||||||
| HEARTCORE ENTERPRISES, INC. | ||||||||
| UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
| For the Nine Months | ||||||||
| Ended September 30, | ||||||||
| 2026 | 2025 | |||||||
| Cash flows from operating activities of continuing operations: | ||||||||
| Net loss | $ | (3,792,658 | ) | $ | (1,724,700 | ) | ||
| Income (loss) from discontinued operations, net of income tax | (644,329 | ) | 710,942 | |||||
| Net loss from continuing operations | (3,148,329 | ) | (2,435,642 | ) | ||||
| Adjustments to reconcile net loss from continuing operations to net cash flows used in operating activities of continuing operations: | ||||||||
| Depreciation expense | 23,023 | 36,994 | ||||||
| Loss on disposal of property and equipment | - | 116,981 | ||||||
| Non-cash lease expense | 195,691 | 28,167 | ||||||
| Gain on termination of lease | - | (9,059 | ) | |||||
| Deferred income taxes | (796,046 | ) | 29,680 | |||||
| Stock-based compensation | 2,031 | 69,222 | ||||||
| Warrants received as noncash consideration | - | (837,913 | ) | |||||
| Changes in fair value of investments in marketable securities | 375,367 | 908,416 | ||||||
| Changes in fair value of investment in warrants | 7,493 | 74,109 | ||||||
| Changes in fair value of derivative liability | 630 | 9,679 | ||||||
| Gain on settlement of asset retirement obligations | - | (45,873 | ) | |||||
| Changes in assets and liabilities: | ||||||||
| Accounts receivable | (32,826 | ) | - | |||||
| Prepaid expenses | 152,391 | 114,556 | ||||||
| Other assets | 93,367 | 137,050 | ||||||
| Accounts payable and accrued expenses | 178,373 | (98,030 | ) | |||||
| Accrued payroll and other employee costs | 988 | (43,430 | ) | |||||
| Due to related party | 138 | - | ||||||
| Operating lease liabilities | (191,710 | ) | (21,135 | ) | ||||
| Income tax payables | 19,382 | (97,537 | ) | |||||
| Deferred revenue | (237,354 | ) | (278,421 | ) | ||||
| Other liabilities | 8,458 | (4 | ) | |||||
| Net cash flows used in operating activities of continuing operations | (3,348,933 | ) | (2,342,190 | ) | ||||
| Cash flows from investing activities of continuing operations: | ||||||||
| Purchases of property and equipment | (4,931 | ) | - | |||||
| Proceeds from sale of marketable securities | 2,076,782 | 1,071,732 | ||||||
| Advances on loan receivable | (256,932 | ) | - | |||||
| Proceeds from sales of discontinued operations, net of cash divested | 825,663 | - | ||||||
| Net cash flows provided by investing activities of continuing operations | 2,640,582 | 1,071,732 | ||||||
| Cash flows from financing activities of continuing operations: | ||||||||
| Payments for finance lease | - | (12,692 | ) | |||||
| Repayment of insurance premium financing | (87,694 | ) | (103,303 | ) | ||||
| Proceeds from issuance of common shares related to at the market offering agreement | - | 30,445 | ||||||
| Proceeds from collection of subscription receivable | - | 103,942 | ||||||
| Proceeds from exercise of stock options | - | 117,000 | ||||||
| Proceeds from issuance of Series A convertible preferred shares and common shares related to securities purchase agreement, net of share issuance costs | - | 1,800,000 | ||||||
| Net cash flows provided by (used in) financing activities of continuing operations | (87,694 | ) | 1,935,392 | |||||
| Cash flows from discontinued operations: | ||||||||
| Net cash flows used in operating activities of discontinued operations | (119,498 | ) | (511,096 | ) | ||||
| Net cash flows provided by (used in) investing activities of discontinued operations | (1,432 | ) | 29,222 | |||||
| Net cash flows used in financing activities of discontinued operations | (22,134 | ) | (305,990 | ) | ||||
| Net cash flows used in discontinued operations | (143,064 | ) | (787,864 | ) | ||||
| Effect of exchange rate changes | (70,259 | ) | 26,577 | |||||
| Net change in cash and cash equivalents | (1,009,368 | ) | (96,353 | ) | ||||
| Cash and cash equivalents - beginning of the period | 1,985,962 | 2,121,089 | ||||||
| Cash and cash equivalents - end of the period | $ | 976,594 | $ | 2,024,736 | ||||
| Supplemental cash flow disclosures: | ||||||||
| Interest paid | $ | 32,583 | $ | 88,321 | ||||
| Income taxes paid | $ | 14,197 | $ | 131,118 | ||||
| Non-cash investing and financing transactions: | ||||||||
| Insurance premium financing | $ | 108,000 | $ | 139,500 | ||||
| Warrants converted to marketable securities | $ | 142,515 | $ | 388,260 | ||||
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities | $ | 552,577 | $ | 23,495 | ||||
| Issuance of common shares related to equity purchase agreement | $ | - | $ | 250,000 | ||||
| Dividends accrued on Series A convertible preferred shares | $ | 62,530 | $ | 56,833 | ||||
| Issuance of common shares for dividends on Series A convertible preferred shares | $ | 67,870 | $ | - | ||||
| Series A convertible preferred shares converted to common shares | $ | 340,146 | $ | - | ||||
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were HeartCore's third-quarter 2026 financial results?
HeartCore reported $162,000 in revenue and a $596,000 net loss for the third quarter of 2026. In the same period last year, revenue was $1.2 million and net income was $351,000. Fewer Go IPO consulting clients and fewer successful client IPOs drove the revenue decline.
How much did HeartCore receive for its HeartCore Luvina stake?
HeartCore completed the transfer of its 51% equity interest in HeartCore Luvina to Luvina Software Joint Stock Company for JPY 29,000,000, approximately $184,000. Together with the June 2026 Sigmaways divestiture, the transaction concluded HeartCore's exit from software development services.
Why have HeartCore's Go IPO clients extended their listing timelines?
HeartCore attributes extended client IPO timelines to stricter exchange and regulatory requirements. The company said it is prioritizing clients it believes have stronger fundamentals, organizational readiness and a clear path to a U.S. listing.